SEROTYPING OF CRYPTOCOCCUS-NEOFORMANS BY USING A MONOCLONAL-ANTIBODY SPECIFIC FOR CAPSULAR POLYSACCHARIDE

被引:59
作者
DROMER, F
GUEHO, E
RONIN, O
DUPONT, B
机构
关键词
D O I
10.1128/JCM.31.2.359-363.1993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The importance of epidemiological studies of cryptococcosis has increased since the beginning of the AIDS epidemic. Cryptococcus neoformans exists in two varieties defining four serotypes, Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). The varieties are easy to distinguish by their differences of growth on diagnostic media. We propose here an easy serotyping method combining diagnostic media and a direct immunofluorescence assay with one monoclonal antibody (E1) specific for cryptococcal polysaccharide. The method was validated by the blinded testing of four to five reference strains of each serotype. Immunofluorescence patterns were characteristic of a given serotype provided that the variety of the strain had been defined before. For C. neoformans var. neoformans, a bright, homogeneous staining with several cell aggregates was characteristic of serotype A, whereas only a few serotype D cells were positive. For C. neoformans var. gattii, a completely negative isolate was serotype C, whereas the population of serotype B included a majority of negative cells but also included positive cells with a speckled pattern. The method was then used to serotype 156 clinical isolates from France and isolates from areas where C. neoformans var. gattii was endemic before the AIDS epidemic (13 strains from Rwanda and Zaire and 5 strains from Australia). The specificity of El was defined by its reactivity with various Cryptococcus spp. and analyzed according to the described cryptococcal antigenic factors. We conclude from this study that E1 provides a rapid and reliable means to serotype multiple isolates of C. neoformans.
引用
收藏
页码:359 / 363
页数:5
相关论文
共 21 条
[1]  
BENNETT JE, 1978, SABOURAUDIA, V16, P167
[2]   EPIDEMIOLOGIC DIFFERENCES AMONG SEROTYPES OF CRYPTOCOCCUS-NEOFORMANS [J].
BENNETT, JE ;
KWONCHUNG, KJ ;
HOWARD, DH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 105 (06) :582-586
[3]  
BHATTACHARJEE AK, 1984, REV INFECT DIS, V6, P619
[4]   ISOLATION OF CRYPTOCOCCUS-NEOFORMANS-GATTII FROM A PATIENT WITH AIDS IN SOUTHERN CALIFORNIA [J].
CLANCY, MN ;
FLEISCHMANN, J ;
HOWARD, DH ;
KWONCHUNG, KJ ;
SHIMIZU, RY .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) :809-809
[5]   CRYPTOCOCCAL MENINGITIS IN PATIENTS WITH AIDS [J].
DISMUKES, WE .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (04) :624-628
[6]   PRODUCTION, CHARACTERIZATION, AND ANTIBODY SPECIFICITY OF A MOUSE MONOCLONAL-ANTIBODY REACTIVE WITH CRYPTOCOCCUS-NEOFORMANS CAPSULAR POLYSACCHARIDE [J].
DROMER, F ;
SALAMERO, J ;
CONTREPOIS, A ;
CARBON, C ;
YENI, P .
INFECTION AND IMMUNITY, 1987, 55 (03) :742-748
[7]  
DUFAIT R, 1987, MYCOSES, V30, P483, DOI 10.1111/j.1439-0507.1987.tb03833.x
[8]   CRYPTOCOCCUS NEOFORMAN - COMPARISONS OF INVITRO ANTIFUNGAL SUSCEPTIBILITIES OF SEROTYPES AD AND BC [J].
FROMTLING, RA ;
ABRUZZO, GK ;
BULMER, GS .
MYCOPATHOLOGIA, 1986, 94 (01) :27-30
[9]  
HENDERSON DK, 1981, 1ST GEN M AM SOC MIC, P315
[10]   ANTIGENIC CHARACTERIZATION OF CRYPTOCOCCUS-NEOFORMANS SEROTYPES AND ITS APPLICATION TO SEROTYPING OF CLINICAL ISOLATES [J].
IKEDA, R ;
SHINODA, T ;
FUKAZAWA, Y ;
KAUFMAN, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 16 (01) :22-29